The effect was dose-dependent
Retatrutide, also known as LY3437943, is a peptide-class triple agonist that activates the GIP, GLP-1, and glucagon receptors, but it is not currently FDA-approved for any indication and is not available as an approved prescription product 1, 2, 3
Days later, I would lash out and binge again
In wellness and metabolic-support settings, Retatrutide is commonly discussed for support with: Difficulty with weight management Increased appetite or cravings Metabolic slowdown Changes in body composition Weight gain resistant to lifestyle modifications Retatrutide is not intended to diagnose, treat, cure, or prevent disease and should only be used under professional medical supervision
Prepare your pen
Compounded GLP-1 options are emphasized publicly, while distinctions around formulation and sourcing resolve later in the process